Posts filtered by tags: Moderna[x]


One of Belgium's top virologists offered his family 4 tips for surviving the long COVID-19 winter — read the full letter he wrote them

Guido Vanham and his son Peter Vanham. Peter Vanham Guido Vanham is a virologist, a microbiologist who studies the rapid spreading of viruses, who's been sending letters to his three children throughout the coronavirus pandemic. The text of his most recent letter is printed below with permission from his son, Peter Vanham. In it, Guido Vanham writes that he's optimistic about the latest major vaccine trial updates but warns that if history and previous viruses are any guide, the toughest t...
Tags: Europe, Science, News, Holidays, Opinion, Trends, Belgium, Pfizer, Nordic, Peter, World Economic Forum, Don, Geneva Switzerland, Antwerp Belgium, Nele, Moderna

Pfizer and Moderna use mRNA in their COVID-19 vaccines. This never-before-used technology could transform how science fights diseases.

Though messenger RNA technology like Pfizer, Moderna use hasn't grabbed headlines before now, some researchers have been working on it for decades.         [Author: USA TODAY]
Tags: Usa, News, Pfizer, Usa Today, Moderna, Pfizer Moderna

Goldman Sachs slashes US growth forecasts as spiking coronavirus cases drive economic slowdown

AP Photo/Sue Ogrocki Spiking COVID-19 cases and slowing economic activity have led Goldman Sachs to cut its near-term growth forecasts. US gross domestic product will grow 3.5% in the fourth quarter, down from the previous forecast of 4.5%, said economists led by Jan Hatzius. The bank's first-quarter 2021 growth estimate was also lowered to 1% from 3.5%. Still, the winter drag should give way to a bigger rebound on the back of vaccine distribution, the bank said. Forecasted second-quarter...
Tags: US, Trends, Astrazeneca, Goldman Sachs, Pfizer, University of Oxford, Federal Reserve, Goldman, FOMC, Fed, Moderna, Jan Hatzius, COVID, Ben Winck

Moderna's CEO sold nearly $2 million of his stock ahead of the company's emergency use vaccine filing. He's now worth $3 billion.

Moderna CEO, Stephane Bancel. Andrew Dunn/Business Insider Moderna CEO Stephane Bancel sold almost $2 million in shares ahead of the company's emergency use authorization filing for its COVID-19 vaccine.Bancel sold a total of 19,000 shares between November 18-19 as part of a predetermined trading plan amended May 21, according to a filing with the SEC.Moderna is the second major drug company to announce success in a late-stage COVID-19 vaccine trial. It expects to file for FDA approval by t...
Tags: Trends, Markets, Billionaires, SEC, Stocks, Fda, Pfizer, Goldman, Pharmaceutical, Pharma Company, Moderna, Healthcare Stocks, Stéphane Bancel, Albert Bourla, Coronavirus, Bancel

The Oxford Vaccine Is 70% Effective, Cheaper and Easier To Store and Distribute

AmiMoJo writes: The coronavirus vaccine developed by the University of Oxford is highly effective at stopping people developing Covid-19 symptoms, a large trial shows. Interim data suggests 70% protection, but the researchers say the figure may be as high as 90% by tweaking the dose. The results will be seen as a triumph, but come after Pfizer and Moderna vaccines showed 95% protection. However, the Oxford jab is far cheaper, and is easier to store and get to every corner of the world than the o...
Tags: UK, Tech, Oxford, Astrazeneca, Boris Johnson, Pfizer, University of Oxford, Moderna, Prof Sarah Gilbert

Oxford University Covid vaccine, cheap and easy to store, is 70-90% effective

Oxford University and AstraZeneca today announced that their Covid vaccine is 70-90% effective depending on the dosing regimen. Though less effective than Pfizer and Moderna's vaccines, the Oxford vaccine is cheap, can be tranpsorted in a cooler, and a single dose can provide immunity. — Read the rest
Tags: Post, News, Oxford, Astrazeneca, Pfizer, Oxford University, Vaccines, Moderna, COVID

A 3rd coronavirus vaccine works

Hollis Johnson/Business Insider Hello,Another Monday, another batch of vaccine results. This time: AstraZeneca and the University of Oxford shared that their coronavirus vaccine was 70% effective on average. That comes on the heels of Pfizer and its partner BioNTech and Moderna both sharing last week that their coronavirus vaccines were 95% and 94.5% effective, respectively. Moncef Slaoui, the scientific head of Operation Warp Speed, is anticipating things will move quickly from here. He s...
Tags: Science, Massachusetts, US, Trends, Atlantic, Healthcare, Argentina, Astrazeneca, National Institutes of Health, Fda, Pfizer, Vaccine, University of Oxford, Oxford University, Santa, Donald Trump

Oil jumps to highest since early September on latest sign of vaccine progress

Drone Base/Reuters Oil futures gained to their highest since September 1 on Monday after AstraZeneca announced its coronavirus vaccine was 70% effective at protecting against COVID-19.The shot — developed in partnership with the University of Oxford — showed 90% and 62% effectiveness across two different dosing regimens. It joins Moderna and Pfizer and BioNTech's promising candidates.The news spurred new optimism for a swift economic recovery and stronger oil demand. West Texas Intermediat...
Tags: US, America, Trends, Nvidia, Astrazeneca, Warren Buffett, Goldman Sachs, Wti, Pfizer, University of Oxford, US Food and Drug Administration, Moderna, Ben Winck, Bank of America saysGoldman Sachs

Veteran investor Jeremy Grantham discussed the dot-com bubble, green investing, and America's poor handling of the pandemic in a recent interview. Here are the 10 best quotes

Morningstar / YouTube British investor Jeremy Grantham reflected on the dot-com bubble, trumpeted green investments, and criticized Americans' response to the pandemic in a RealVision interview released on Monday.The chief investment strategist of asset-manager GMO also praised Pfizer's partner BioNTech and Moderna for developing extremely effective COVID-19 vaccines in record time.Scroll down to read his 10 best quotes from the interview.Visit Business Insider's homepage for more stori...
Tags: Congress, US, America, Trends, Gmo, Warren Buffett, Pfizer, Goldman, Grantham, Morningstar, Alan Greenspan, Jeremy Grantham, Grantham Mayo van Otterloo, Moderna, BioNtech, General Electrics

Covid: Oxford AstraZeneca vaccine has up to 90% efficacy, data reveals

Vaccine developed in UK by AstraZeneca and Oxford University ‘will save many lives’, says scientistCoronavirus – latest updatesSee all our coronavirus coverageThe Covid vaccine developed in the UK by Oxford University and AstraZeneca can protect 70.4% of people from becoming ill and – in a surprise result – up to 90% if a lower first dose is used, results from the final trial show.The Oxford vaccine is the third to produce efficacy results, following Pfizer/BioNTech and Moderna whose vaccines we...
Tags: Health, UK, Science, US, Society, World news, Medical Research, Infectious Diseases, Oxford, Astrazeneca, Vaccines and immunisation, Pfizer, Oxford University, Moderna, Coronavirus, Oxford AstraZeneca

This COVID vaccine is effective, cheaper and can be transported in a normal refrigerator

By DANICA KIRKA and JILL LAWLESS | Associated Press LONDON — Pharmaceutical company AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to 90% effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its rivals. The results are based on interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca. No hospitalizations ...
Tags: Business, London, News, Sport, World news, Soccer, Oxford, Brazil, World Health Organization, Astrazeneca, Vaccinations, Associated Press, Pfizer, Pascal Soriot, Oxford University, Latin America

The Covid vaccine results are great news, but it's not all over yet

Oxford/AstraZeneca findings have certain advantages over those from other versionsCoronavirus – latest updatesSee all our coronavirus coverageWithin weeks, the prospects of an end to the pandemic have changed utterly, with three vaccines against Covid-19 reporting good results in final clinical trials and at least one likely to be used before Christmas. But there are still huge challenges ahead.The results from the Oxford University/AstraZeneca vaccine, which is absolutely central to the UK’s va...
Tags: Health, UK, UK News, Medical Research, Infectious Diseases, Health policy, Astrazeneca, Vaccines and immunisation, University of Oxford, Moderna, Coronavirus, COVID, Pfizer BioNTech, Oxford University AstraZeneca, Oxford AstraZeneca

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full strength does were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full strength dose to follow – that one was 90% effective. Oxford’s results may not ...
Tags: Health, TC, Messenger, Medicine, Tech, Medical Research, Oxford, Vaccination, Astrazeneca, Pfizer, Vaccine, Oxford University, Biotech, Vaccines, Moderna, COVID

Oxford and AstraZeneca's COVID-19 vaccine is considerably cheaper and easier to distribute than either Pfizer's or Moderna's. Here's why.

A half-dose of Oxford-AstraZeneca's COVID-19 vaccine initially could mean we have double the number doses available when it's approved by regulators. Siphiwe Sibeko/Pool via AP The University of Oxford and AstraZeneca's COVID-19 vaccine can be stored at normal fridge temperatures for at least six months. Unlike Pfizer and BioNTech's vaccine, it therefore doesn't require an ultra-cold storage and transport system, making it cheaper to distribute globally. The price per dose is also ...
Tags: Minnesota, US, Trends, Eu, Healthcare, Oxford, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, Welt am Sonntag, Andrew Pollard, Moderna, Siphiwe Sibeko, Stéphane Bancel

AstraZeneca and Oxford University's vaccine is effective at preventing COVID-19, trial results suggest. Here's everything we know so far.

Screen grab taken from video issued by Britain's Oxford University, showing a person being injected as part of the first human trials in the UK to test a potential coronavirus vaccine, untaken by Oxford University in England, Thursday April 23, 2020 Oxford University Pool via AP On Monday, AstraZeneca and The University of Oxford released results for their large-scale trial, which showed their COVID-19 vaccine was 70% effective.  The Oxford vaccine is administered in two doses at least...
Tags: Europe, UK, England, US, Trends, Ap, Bbc, Britain, South Africa, Astrazeneca, Pfizer, University of Oxford, Oxford University, Agency, BBC Radio, Welt am Sonntag

A Glimmer of Light Ahead for the Aviation Industry

Boeing 737 MAX 7 For the thousands of us who call the aviation industry home, 2020 turned out to be a year we’ll be glad to see the end of although the change of calendars won’t wipe away many of this year’s problems. The highly-contagious coronavirus wreaking havoc on our planet stuck its ugly tentacles into nearly every aspect of life on Earth this year. The result has been people fleeing airline travel and anything related in unprecedented numbers. Airlines around the globe reacted by parkin...
Tags: Congress, Cdc, Washington, US, America, Joe Biden, Earth, First, United States, Aviation, Pfizer, Biden, Donald Trump, Faa, Boeing, Trump

AstraZeneca slides after announcing its COVID-19 vaccine candidate is 70% effective

AP Photo/Ted S. Warren Shares in AstraZeneca slid 2% on Monday after the company released results that showed its COVID-19 vaccine is just 70% effective, compared with rates of above 90% for those of its two biggest rivals.The Oxford/AstraZeneca vaccine is cheaper to produce and easier to transport than those of US peers Pfizer and Moderna, but is clearly less effective than the other two.AstraZeneca said its vaccine can be stored in normal refrigerated conditions.Visit Business Insider's ...
Tags: Europe, UK, US, Trends, Brazil, Astrazeneca, Pfizer, Oxford University, Goldman, Moderna, Oxford AstraZeneca, Shalini Nagarajan, Pfizer Pfizer, AP Photo Ted S Warren Shares

'A new era': Success of Pfizer and Moderna COVID-19 mRNA vaccines a major breakthrough

Coronavirus vaccines from Pfizer and Moderna are based on messenger RNA technology that could transform the way science fights diseases.         [Author: USA TODAY]
Tags: Usa, News, Pfizer, Usa Today, Moderna

Global stocks rise as the US plans first COVID-19 vaccinations by mid-December

Thomson Reuters Global stocks rose on Monday as the head of the White House's Operation Warp Speed said some Americans would be able to receive coronavirus vaccinations by mid-December.Investors are betting that positive developments in trials of COVID-19 vaccines might mean swift regulatory approval and a quick rollout.The greatest potential is in the sectors with scope to "catch up" as the vaccine rollout and policy support facilitate economic recovery, said UBS' Mark Haefele.AstraZeneca...
Tags: Hong Kong, Japan, London, White House, China, Germany, Global, US, Trends, Fda, Pfizer, Goldman, Shanghai Composite, Mark Haefele, Moderna, Steve Mnuchin

AstraZeneca and Oxford University announced a 3rd working COVID-19 vaccine, which they say is 70% effective

Researchers said the trial of more than 20,000 volunteers showed the vaccine stopped people from developing symptoms about 70% of the time on average. Carol Smiljan/NurPhoto via Getty Images The University of Oxford and AstraZeneca released positive results for their COVID-19 vaccine on Monday. In a statement, they said the vaccine is 70% effective on average. It follows results being released for two other vaccines — developed by Pfizer and Moderna — which are 95% effective. The Oxford/As...
Tags: Europe, Japan, UK, Science, Trends, Bbc, Astrazeneca, Pfizer, Vaccine, University of Oxford, Oxford University, European Medicines Agency, EMA, Moderna, Coronavirus, COVID-19

AstraZeneca, Oxford: Coronavirus vaccine is 70 percent effective

The announcement comes after news from Moderna and the Pfizer/BioNTech vaccine trials, which both showed efficacy of over 90 percent.
Tags: Pfizer, Moderna, AstraZeneca Oxford

Moderna planning to charge governments $25-$37 for its COVID-19 vaccine Moderna’s CEO Stephane Bancel has announced that they are planning to charge $25-$37 (depending on the quantity ordered) for their Covid-19 vaccine. He was reportedly quoted saying “Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50.”  Moderna had earlier announced that it has developed a new vaccine for Covid-19 and the vaccine was 94.5% effective in pr...
Tags: Business, News, Moderna, Stéphane Bancel, Covid-19 Vaccine

Patently-O Bits and Bytes by Juvan Bonni

Recent Headlines in the IP World: Atty. Alan Macek and Atty. Richard Mar: Canadian Intellectual Property Office Issues Practice Notice Regarding Patentable Subject Matter (Source: Lexology) Atty. Daniel Shores and Atty. Dylan Haversack: COVID-19 Vaccine Leader Moderna “Not Aware of Any Significant Intellectual Property Impediments” in Development of its Vaccine Despite Mixed Results at PTAB (Source: JD Supra) Catherine Putz: Farley on Patents and Power: Where Intellectual Property Law and Mil...
Tags: Law, Patent, Farley, Richard Epstein, Moderna, Bits and Bytes, Juvan Bonni, Daniel Shores, COVID, Alan Macek, Richard Mar, JD Supra Catherine Putz, Alan Coté, Yu Kai Lin, Arun Rai

Stephen Moore says that Trump will leave office 'triumphant,' comparing him to Winston Churchill

Stephen Moore. Samuel Corum/Getty Images Stephen Moore, a conservative economist, said in a Sunday radio interview that President Donald Trump would leave office on a high note due to the progress with COVID-19 vaccines and the economy. Moore touted the president's handling of the coronavirus with New York businessman John Catsimatidis. "I think he is going to leave the office triumphant," Moore said of the president. "By early next year, we will have a vaccine that nobody thought was poss...
Tags: Politics, New York, US, Trends, Georgia, Joe Biden, Economy, Winston Churchill, Pfizer, Gdp, Parliament, Conservative Party, Biden, Donald Trump, Churchill, Trump

WH Vaccine Czar Predicts Herd Immunity From COVID Vaccine By May. Fauci Thinks Not.

White House coronavirus task force member Dr. Anthony Fauci and Dr. Moncef Slaoui, chief adviser of Operation Warp Speed, offered conflicting takes on Sunday regarding herd immunity as a result of COVID-19 vaccines. Herd immunity has been pushed by Dr. Scott Atlas, Trump’s favorite COVID-19 adviser who opposes lockdowns and often espouses Trump rosy view on the pandemic that has killed more than 250,000 Americans thus far. Last week, President-elect Joe Biden rebuked Trump on Wednesday for sta...
Tags: News, White House, US, Joe Biden, Cnn, United States, Fda, Pfizer, Biden, Anthony Fauci, Trump, Fauci, Moderna, Summer Concepcion, Slaoui, Moncef Slaoui

Coronavirus vaccine czar said Moderna will seek an emergency use authorization for its vaccine by the end of November

Moderna will seek emergency use authorization from the Food and Drug Administration for its COVID-19 vaccine by the end of the month, the coronavirus vaccine czar said Sunday. Moderna; Samantha Lee/Business Insider Moderna, the biotech company that last week announced the results of its COVID-19 vaccine, will apply with the Food and Drug Administration for an emergency use authorization by the end of the month, Moncef Slaoui, the head of the White House Operation "Warp Speed" said Sunday. ...
Tags: Science, News, Abc, US, Trends, Healthcare, Food And Drug Administration, Fda, GlaxoSmithKline, Pfizer, Vaccine, Abc News, Moderna, Slaoui, Moncef Slaoui, Connor Perrett

The vaccine breakthroughs at Moderna and Pfizer are the latest examples of how immigrants have been driving billions in American innovation for decades

Noubar Afeyan, an immigrant from Lebanon, is the co-founder and chairman of Moderna, the company behind one of the most promising potential COVID019 vaccines. Flagship Pioneering Behind both Moderna and the Pfizer-BioNTech potential coronavirus vaccines are a group of incredible scientists, biotech CEOs, and venture capitalists funding the effort — many of whom are immigrants. Business Insider spoke with Moderna cofounder and chairman Noubar Afeyan, an immigrant himself, abou...
Tags: Spacex, Elon Musk, Greece, France, Germany, Russia, US, America, Trends, Tesla, Bloomberg, Turkey, Joe Biden, Mit, Cologne, Canada

Keeping coronavirus vaccines in a deep freeze one of California’s big challenges

Some are bigger than the fridge in your kitchen. Others are as small as the cooler you lug to the beach. They’re way colder than the Arctic, in extremely high demand and absolutely essential for getting the first wave of coronavirus vaccines — “the proverbial light at the end of this very long, dark tunnel,” as Gov. Gavin Newsom said — from the manufacturer into your body. Most of these specialized freezers cost $7,000 to $15,000 each, with the most imposing models topping out at $26,000 — and C...
Tags: News, California, Cdc, La, Sport, UPS, Public Health, Soccer, Arctic, Ohio, Vaccinations, Fda, Pfizer, Pasadena, Fedex, Gavin Newsom

We run the largest health system in New York and treated more than 100,000 COVID cases. Here's how the US can better tackle the pandemic.

Nurse Practitioner Gabriela Huyke prepares for medical examination of a volunteer for the COVID-19 vaccine study at the Research Centers of America (RCA) in Hollywood, Florida, on August 13, 2020. Chandan Khanna/AFP via Getty Northwell Health has treated more than 100,000 COVID-19 cases since March and we've learned valuable lessons.  While we wait for a vaccine, we need to keep researching new treatment therapies, establish a governance structure at each research enterprise, and stop poli...
Tags: New York, US, Trends, Fda, Afp, Hollywood Florida, Northwell Health, Food Drug Administration, Moderna, US Department of Health Human Services, Chandan Khanna, Kevin J Tracey MD, Michael J Dowling, COVID, Kevin Tracey, Northwell Health New York

Americans will hopefully begin receiving the COVID-19 vaccine as early as December 11, 'Warp Speed' advisor says

Some Americans could "hopefully" receive the vaccine for COVID-19 as soon as December 11 or 12, Moncef Slaoui said Dado Ruvic/Reuters Moncef Slaoui, the head of the White House "Operation Warp Speed" said on Sunday that some Americans will begin receiving the vaccine for COVID-19 as soon as December 11.  A panel of outside experts that advises the FDA is expected to meet on December 10 to discuss Pfizer's application for an emergency use authorization, but it's not clear how quickly FDA wo...
Tags: Science, News, White House, Trends, Cnn, United States, Healthcare, Food And Drug Administration, Fda, GlaxoSmithKline, Pfizer, Jake Tapper, Moderna, Slaoui, Moncef Slaoui, Connor Perrett